To receive one share at no cost in MDSystems for every listed BPH share you hold at the record date you will need to have purchased your shares in BPH by no later that COB Thursday, 24 December 2009.  Shareholders must hold their BPH shares for five days after the date of shareholder approval of the spin-off which will be sought at the General Meeting on the same day.

BPH Corporate shares are listed on the ASX with the code BPH.

The Annual General Meeting will be held on Friday, 15 January 2010.

Notices of Meeing for the General Meeting and the Annual General Meeting are now being dispatched to shareholders.

BPH Corporate's representatives attended BIO2008 in San Diego to discuss with international pharma groups the potential licensing opportunities for HLS5.

Dr Louis Winteringham presented on HLS5 at the Signalling and Cancer Symposium (ComBio) in Canberra.  Louise also presented a poster at the American Society of Hematology (ASH) reporting the findings concerning the role of HLS5 in controlling gene regulation and differentiation of leukemia cells.

The Western Australia Institute for Medical Research (WAIMR) research team were accepted for publication reporting their important findings concerning the role of HLS5 in controlling gene-regulation and cell differentiation in the respected journal Blood.

BPH Corporate undertook an extensive high-throughout screening of 70,000 synthetic compounds yielding molecules that demonstrate potential for further anti-tumour analysis and drug development.

Molecular Discovery Systems a wholly owned subsidery of BPH Corporate successfully completed a Collaborative Research Agreement with GE Healthcare, one of the worlds largest healthcare companies.

Diagnostic Array Systems an investee company of BPH Corporate won a Commercial Ready Grant in 2007 to improve diagnosis using the DNA-based BacTrak System and completed the grant in 2008.

Dr Peter King was appointed the new Chief Executive Officer for BPH Corporate Limted.  Peter was also invited to sit on the selection panel of the Science and Innovation Studentship Awards (SISA) this year.

BPH Corporate Limited takes great pleasure in congratulating Alison Mees on her success in winning a 2007 Department of Industry & Resources Studentship Award. The studentship award will see Alison test novel compounds for anti-cancer properties.